Editor's note: This roundup is intended to highlight some of the month's most high-profile funding rounds, but it is not comprehensive.
Health technology companies made several major funding announcements in December. Here is a list of some of the largest funding rounds.
Curative receives $150 million in Series B financing
Headquartered in Austin, Texas, Curative offers employer-based health plans with $0 out-of-pocket costs, including no deductibles, no deductibles and coinsurance. Members receive $0 out-of-pocket simply by completing an annual preventive health exam.
The Series B round of financing was led by TED Chairman Chris Anderson’s Upside Vision Fund, and JAM Fund founder Justin Mateen also participated. Other investors include Galaxy Digital's Mike Novogratz, Stanley Druckenmiller's Duquesne Family Office, DCVC and Martin Varsavsky. The announcement stated that this financing will help expand Curative’s business scale across the country.
Angle Health raises $134M in Series B funding
San Francisco-based Angle Health is a company that provides digital health care benefits to employers. Its artificial intelligence application provides care navigation services through its care teams. Its customizable health plans include telemedicine, behavioral health and other digital health solutions. The company also helps process payments, billing and invoicing and serves more than 3,000 employers in 44 states.
Angle Health's Series B round was led by Portage, with participation from Blumberg Capital, Mighty Capital, PruVen Capital, SixThirty Ventures, TSVC, Wing VC and Y Combinator. The funding round includes a mix of debt and equity. Angle Health has raised about $200 million in total.
Paradigm Health secures $78 million in Series B financing
Paradigm Health provides an AI-powered platform designed to provide patients with equitable access to clinical trials. The platform automatically matches patients to clinical trials and helps health systems attract eligible patients to trials.
The round was led by ARCH Venture Partners, with participation from DFJ Growth, F-Prime, General Catalyst, GV, Lux Capital, Mubadala Capital and the American Cancer Society BrightEdge Fund. The financing “will be used to accelerate Paradigm Health's expansion as global biopharmaceutical companies grow in demand for more effective trials and health systems seek to deliver trials closer to patients receiving routine care,” the announcement said.
Artera raises $65 million in funding
Santa Barbara, California-based Artera is a healthcare technology company that uses artificial intelligence to help providers communicate with patients more easily. Its platform uses automated text, voice and web messaging to handle things like appointment scheduling, intake and billing.
The round includes support from Lead Edge Capital, Jackson Square Ventures, Health Velocity Capital, Heritage Medical Systems and Summation Health Ventures. It will help Artera further grow its company and adopt agent artificial intelligence in healthcare.
Photo: Abscent84, Getty Images
